Insider · CIK 0002049585
Wendy Lynn Barnes
Files at GDRX (GoodRx Holdings, Inc.). First filing -, latest -.
In brief
Wendy Lynn Barnes files SEC Form 4 as officer and director at GDRX (GoodRx Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Wendy Lynn Barnes has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 28 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +115,148 | - | - | 699,973 | Jul 16, 2026 |
| Jul 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -50,021 | $3.01 | $151k | 649,952 | Jul 16, 2026 |
| Jul 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +51,177 | - | - | 701,129 | Jul 16, 2026 |
| Jul 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -22,232 | $3.01 | $67k | 678,897 | Jul 16, 2026 |
| Jul 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +110,963 | - | - | 789,860 | Jul 16, 2026 |
| Jul 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -48,203 | $3.01 | $145k | 741,657 | Jul 16, 2026 |
| Jul 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -115,148 | $0.00 | $0 | 1,151,484 | Jul 16, 2026 |
| Jul 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -51,177 | $0.00 | $0 | 102,354 | Jul 16, 2026 |
| Jul 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -110,963 | $0.00 | $0 | 1,109,631 | Jul 16, 2026 |
| Apr 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +115,148 | - | - | 543,141 | Apr 15, 2026 |
| Apr 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -50,021 | $2.23 | $112k | 493,120 | Apr 15, 2026 |
| Apr 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +51,177 | - | - | 544,297 | Apr 15, 2026 |
| Apr 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -22,232 | $2.23 | $50k | 522,065 | Apr 15, 2026 |
| Apr 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +110,963 | - | - | 633,028 | Apr 15, 2026 |
| Apr 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -48,203 | $2.23 | $107k | 584,825 | Apr 15, 2026 |
| Apr 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -115,148 | $0.00 | $0 | 1,266,632 | Apr 15, 2026 |
| Apr 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -51,177 | $0.00 | $0 | 153,531 | Apr 15, 2026 |
| Apr 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -110,963 | $0.00 | $0 | 1,220,594 | Apr 15, 2026 |
| Mar 3, 2026 | GDRX GoodRx Holdings, Inc. | AGrant or award Restricted Stock Unitderivative | +1,331,557 | $0.00 | $0 | 1,331,557 | Mar 5, 2026 |
| Jan 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +460,594 | - | - | 460,594 | Jan 15, 2026 |
| Jan 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -148,383 | $2.75 | $408k | 312,211 | Jan 15, 2026 |
| Jan 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +204,708 | - | - | 516,919 | Jan 15, 2026 |
| Jan 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -88,926 | $2.75 | $245k | 427,993 | Jan 15, 2026 |
| Jan 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -460,594 | $0.00 | $0 | 1,381,780 | Jan 15, 2026 |
| Jan 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -204,708 | $0.00 | $0 | 204,708 | Jan 15, 2026 |
| Mar 3, 2025 | GDRX GoodRx Holdings, Inc. | AGrant or award Restricted Stock Unitderivative | +1,842,374 | $0.00 | $0 | 1,842,374 | Mar 5, 2025 |
| Mar 3, 2025 | GDRX GoodRx Holdings, Inc. | AGrant or award Restricted Stock Unitderivative | +409,416 | $0.00 | $0 | 409,416 | Mar 5, 2025 |
| Mar 3, 2025 | GDRX GoodRx Holdings, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +2,828,232 | $0.00 | $0 | 2,828,232 | Mar 5, 2025 |
Questions about Wendy Lynn Barnes
Answered from the filings on this page, as of the latest one.
Is Wendy Lynn Barnes buying or selling?
Wendy Lynn Barnes has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Wendy Lynn Barnes's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Wendy Lynn Barnes has 0.
Where does Wendy Lynn Barnes file Form 4?
Wendy Lynn Barnes has filed Form 4 at GDRX (GoodRx Holdings, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.